EyePoint Pharmaceuticals (EYPT)
(Delayed Data from NSDQ)
$9.10 USD
+0.22 (2.48%)
Updated Sep 13, 2024 04:00 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Earnings News For EYPT
-
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Misses Revenue Estimates
-
EyePoint Pharmaceuticals: Q2 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments
-
EyePoint Pharmaceuticals: Q1 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
-
EyePoint Pharmaceuticals: Q4 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments
-
Will EyePoint Pharmaceuticals (EYPT) Report Negative Q4 Earnings? What You Should Know
-
EyePoint Pharmaceuticals: Q3 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments
-
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Lags Revenue Estimates
-
EyePoint Pharmaceuticals: Q2 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments
-
EyePoint Pharmaceuticals: Q1 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Developments
-
EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Tops Revenue Estimates
-
EyePoint Pharmaceuticals: Q4 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Developments
-
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates
-
EyePoint Pharmaceuticals: Q3 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Developments
-
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Tops Revenue Estimates
-
EyePoint Pharmaceuticals: Q2 Earnings Snapshot
-
EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments
-
EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Lags Revenue Estimates